Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 43817-906

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 43817-906). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Panacea Biotec Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Azacitidine 01

Chemical structure of azacitidine, showing its molecular framework with nitrogen and oxygen atoms, hydroxyl groups, and amino group as part of the nucleoside analog structure.*

FDA Label Image

Azacitidine 02

A Kaplan-Meier survival curve comparing the proportion surviving over time (months) from randomization between two groups: AZA and CCR. The y-axis represents the proportion surviving from 0 to 1, and the x-axis shows time up to 40 months. The graph includes a log-rank p-value, hazard ratio (HR) with confidence interval, and the number at risk at multiple time points for each group.*

FDA Label Image

Azacitidine 03

Azacitidine for Injection 100 mg/vial powder for solution carton, manufactured by Panacea Biotec Pharma Limited and distributed by Breckenridge Pharmaceutical, Inc. Label states single-dose vial for subcutaneous and intravenous use only, Rx only, with storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.